Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.

The British journal of dermatology - 1 Feb 2016

Tschandl P, Berghoff A S, Preusser M, Pammer J, Pehamberger H, Kittler H

Abstract excerpt

BACKGROUND: It is important to know what drives and arrests melanocytic growth in vivo but observations linking oncogenic mutations to growth rates of melanocytic neoplasms in vivo are sparse. OBJECTIVES: To clarify the relationship between BRAF(V) (600E) mutations and p16 expression and the growth rate of melanocytic neoplasms in vivo. METHODS: We measured the growth rate of 54 melanocytic lesions (26 melanomas,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Enlargement
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p16

Share to Melanocytes

Share to Melanoma

Share to Nevus, Pigmented

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Identifiers

PMID: 26613644
DOI: 10.1111/bjd.14323

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.PMID 26613644Read ↗

Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns.Semantic proximity Read ↗

BRAF somatic mutations in malignant melanoma and melanocytic naevi.Semantic proximity Read ↗

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.Semantic proximity Read ↗

Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.Semantic proximity Read ↗

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation.Semantic proximity Read ↗

BRAF kinase gene V599E mutation in growing melanocytic lesions.Semantic proximity Read ↗

Melanocytic nevi and melanoma: unraveling a complex relationship.Semantic proximity Read ↗

Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration.Semantic proximity Read ↗

Tumorigenesis driven by the BRAF <sup>V600E</sup> oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasionSemantic proximity Read ↗

V599EB-RAF is an Oncogene in MelanocytesSemantic proximity Read ↗

Decoding the Molecular Mechanisms of BRAF V600E-Induced Nevi Formation.Semantic proximity Read ↗

The role of BRAF mutations in primary melanoma growth rate and survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.